Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAX 325: Docetaxel in Advanced Gastric Cancer
NCT00290966Phase 3Completed
- Sponsor
- Sanofi
- Start
- Oct 1998
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of docetaxel in gastric adenocarcinoma, sponsored by Sanofi. Started Oct 1998; status: completed.
02
Drugs
docetaxel
03
Conditions
gastric adenocarcinoma
Beyond the preview
Go deeper on NCT00290966.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00290966.